KLK3 and prostate carcinoma: Consistent with other studies38,39, PSA (KLK3) protein abundance was consistently significantly reduced in all fractions of urine from prostate cancer patients relative to men without a cancer diagnosis, despite being increased in serum and in tumor regions19 (Fig. 5c–e).